Key facts
- Hangzhou Qinglan Junke Equity Investment is a other based in Hangzhou, Zhejiang with 1 tracked portfolio company.
- Notable positions include Defand Therapeutics.
About Hangzhou Qinglan Junke Equity Investment
Hangzhou Qinglan Junke Equity Investment is a direct investment firm based in Hangzhou, China. Established in 2020, the firm specializes in the design, production, and sale of general equity investment products. The assets are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Hangzhou Qinglan Junke Equity Investment's activity
Create free account
No card required
Portfolio, priced
1 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Defand Therapeutics | — | — | — |
Frequently asked
- What companies does Hangzhou Qinglan Junke Equity Investment invest in?
- Hangzhou Qinglan Junke Equity Investment has 1 recorded portfolio companies, including Defand Therapeutics.